Sivik Global Healthcare LLC Purchases 20,000 Shares of Thermo Fisher Scientific Inc. (TMO)
Sivik Global Healthcare LLC increased its position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 80.0% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 45,000 shares of the medical research company’s stock after acquiring an additional 20,000 shares during the quarter. Thermo Fisher Scientific comprises approximately 2.9% of Sivik Global Healthcare LLC’s investment portfolio, making the stock its 4th biggest holding. Sivik Global Healthcare LLC’s holdings in Thermo Fisher Scientific were worth $8,514,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently added to or reduced their stakes in TMO. Winslow Capital Management LLC raised its holdings in Thermo Fisher Scientific by 25.0% during the 1st quarter. Winslow Capital Management LLC now owns 2,198,174 shares of the medical research company’s stock worth $337,639,000 after buying an additional 439,847 shares during the period. Rosenblum Silverman Sutton S F Inc. CA raised its holdings in Thermo Fisher Scientific by 1.6% during the 1st quarter. Rosenblum Silverman Sutton S F Inc. CA now owns 43,813 shares of the medical research company’s stock worth $6,730,000 after buying an additional 669 shares during the period. Dimensional Fund Advisors LP raised its holdings in Thermo Fisher Scientific by 2.1% during the 1st quarter. Dimensional Fund Advisors LP now owns 2,835,460 shares of the medical research company’s stock worth $435,527,000 after buying an additional 57,480 shares during the period. Caisse DE Depot ET Placement DU Quebec raised its holdings in Thermo Fisher Scientific by 4.3% during the 1st quarter. Caisse DE Depot ET Placement DU Quebec now owns 901,182 shares of the medical research company’s stock worth $138,572,000 after buying an additional 37,400 shares during the period. Finally, Johnson Financial Group Inc. raised its holdings in Thermo Fisher Scientific by 2.5% during the 1st quarter. Johnson Financial Group Inc. now owns 1,619 shares of the medical research company’s stock worth $249,000 after buying an additional 39 shares during the period. 86.16% of the stock is currently owned by institutional investors and hedge funds.
Several analysts have commented on the stock. Deutsche Bank set a $226.00 target price on shares of Thermo Fisher Scientific and gave the stock a “buy” rating in a report on Thursday, October 26th. Zacks Investment Research downgraded shares of Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a report on Tuesday, September 12th. Leerink Swann lifted their price objective on shares of Thermo Fisher Scientific from $190.00 to $207.00 and gave the company an “outperform” rating in a report on Monday, October 9th. Finally, Cowen reiterated an “outperform” rating and issued a $220.00 price objective (up from $200.00) on shares of Thermo Fisher Scientific in a report on Sunday, September 10th. One analyst has rated the stock with a hold rating and sixteen have given a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average price target of $205.21.
Thermo Fisher Scientific Inc. (TMO) traded up $2.33 during midday trading on Monday, hitting $187.96. 2,437,700 shares of the stock were exchanged, compared to its average volume of 1,564,998. The company has a quick ratio of 0.81, a current ratio of 1.26 and a debt-to-equity ratio of 0.85. Thermo Fisher Scientific Inc. has a 12 month low of $139.88 and a 12 month high of $201.20. The firm has a market capitalization of $75,371.09, a P/E ratio of 20.66, a PEG ratio of 1.72 and a beta of 1.06.
Thermo Fisher Scientific (NYSE:TMO) last posted its quarterly earnings data on Wednesday, October 25th. The medical research company reported $2.31 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.24 by $0.07. Thermo Fisher Scientific had a net margin of 11.73% and a return on equity of 15.94%. The company had revenue of $5.12 billion for the quarter, compared to the consensus estimate of $5.03 billion. During the same period last year, the company earned $2.03 earnings per share. The firm’s revenue was up 13.9% compared to the same quarter last year. sell-side analysts predict that Thermo Fisher Scientific Inc. will post 9.36 earnings per share for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, January 15th. Stockholders of record on Friday, December 15th will be issued a $0.15 dividend. The ex-dividend date of this dividend is Thursday, December 14th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.32%. Thermo Fisher Scientific’s dividend payout ratio (DPR) is presently 10.19%.
TRADEMARK VIOLATION NOTICE: This piece was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece on another domain, it was copied illegally and reposted in violation of US & international copyright laws. The correct version of this piece can be read at https://www.thecerbatgem.com/2017/12/11/sivik-global-healthcare-llc-purchases-20000-shares-of-thermo-fisher-scientific-inc-tmo.html.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
Receive News & Stock Ratings for Thermo Fisher Scientific Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc. and related stocks with our FREE daily email newsletter.